,.
Invest Ophthalmol Vis Sci. 2020 Jun 3;61(6):2. doi: 10.1167/iovs.61.6.2.
PURPOSE: Epithelial to mesenchymal transition (EMT) is a cause of anterior and posterior subcapsular cataracts. Central to EMT is the formation of actin stress fibers. Selective targeting of actin stress fiber-associated tropomyosin (Tpm) in epithelial cells may be a means to prevent stress fiber formation and repress lens EMT. METHODS: We identified Tpm isoforms in mouse immortalized lens epithelial cells and epithelial and fiber cells from whole lenses by semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) followed Sanger sequencing. We focused on the role of one particular tropomyosin isoform, Tpm3.1, in EMT. To induce EMT, we treated cells or native lenses with TGFβ2. To test the function of Tpm3.1, we exposed cells or whole lenses to a Tpm3.1-specific chemical inhibitor, TR100, as well as investigated lenses from Tpm3.1 knockout mice. We examined stress fiber formation by confocal microscopy and assessed EMT progression by analysis of alpha-smooth muscle actin (αSMA) mRNA (real-time RT-PCR), and protein (Western immunoassay [WES]). RESULTS: Lens epithelial cells express eight Tpm isoforms. Cell culture studies showed that TGFβ2 treatment results in the upregulation of Tpm3.1, which associates with actin in stress fibers. TR100 prevents stress fiber formation and reduces αSMA in TGFβ2-treated cells. Using an ex vivo lens culture model, TGFβ2 treatment results in stress fiber formation at the basal regions of the epithelial cells. Genetic knockout of Tpm3.1 or treatment of lenses with TR100 prevents basal stress fiber formation and reduces epithelial αSMA levels. CONCLUSIONS: Targeting specific stress fiber associated tropomyosin isoform, Tpm3.1, is a means to repress lens EMT.
目的:上皮-间充质转化(EMT)是造成前囊和后囊下白内障的原因。EMT 的核心是形成肌动蛋白应力纤维。选择性针对上皮细胞中肌动蛋白应力纤维相关原肌球蛋白(Tpm)进行靶向治疗,可能是防止应力纤维形成和抑制晶状体 EMT 的一种手段。
方法:我们通过半定量逆转录-聚合酶链反应(RT-PCR)结合 Sanger 测序,鉴定了小鼠永生化晶状体上皮细胞以及整个晶状体中的上皮细胞和纤维细胞中的 Tpm 同工型。我们重点研究了一种特定的原肌球蛋白同工型 Tpm3.1 在 EMT 中的作用。为了诱导 EMT,我们用 TGFβ2 处理细胞或原生晶状体。为了测试 Tpm3.1 的功能,我们用 Tpm3.1 特异性化学抑制剂 TR100 暴露细胞或整个晶状体,并研究 Tpm3.1 敲除小鼠的晶状体。我们通过共聚焦显微镜检查应力纤维的形成,并通过分析α-平滑肌肌动蛋白(αSMA)mRNA(实时 RT-PCR)和蛋白质(Western 免疫印迹[WES])来评估 EMT 进展。
结果:晶状体上皮细胞表达八种 Tpm 同工型。细胞培养研究表明,TGFβ2 处理导致 Tpm3.1 的上调,Tpm3.1 与应力纤维中的肌动蛋白结合。TR100 可防止 TGFβ2 处理的细胞中应力纤维的形成并减少 αSMA。使用离体晶状体培养模型,TGFβ2 处理导致上皮细胞的基底区域形成应力纤维。Tpm3.1 的基因敲除或用 TR100 处理晶状体可防止基底应力纤维的形成并降低上皮细胞 αSMA 水平。
结论:针对特定的与应力纤维相关的原肌球蛋白同工型 Tpm3.1 是抑制晶状体 EMT 的一种手段。
Invest Ophthalmol Vis Sci. 2020-6-3
Transl Vis Sci Technol. 2024-7-1
Invest Ophthalmol Vis Sci. 2017-2-1
Cytoskeleton (Hoboken). 2024-11-27
Eur J Cell Biol. 2024-6
Cartilage. 2024-1-6
Semin Cell Dev Biol. 2020-6
Mol Biol Cell. 2019-1-16
Invest Ophthalmol Vis Sci. 2018-10-1
Mol Biol Cell. 2018-4-10
Exp Eye Res. 2018-4-1
Biochemistry (Mosc). 2016-12